News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

Flash

News

Markets

VIP news

Calendar

All

Crypto

Stocks

Commodities & Forex

Macro

1FOMC Preview: Warsh's First Show — Can Risk On Continue?【Buy US Spot Stocks, Get NVIDIA Free】2Hormuz Strait Reopens: Will the Federal Reserve Pivot Dovishly and Will the Market Reprice Rate Cuts?3US Stock Market Financing Hits Historical Limit! Morgan Stanley Warns: A Deleveraging Storm is Brewing

Ethereum Foundation has received a confidential enquiry from a state authority, shows GitHub commit

The Ethereum Foundation has received a voluntary and confidential enquiry from an unspecified state authority, according to the foundation’s GitHub repository. As a result, the foundation has removed the “Warrant Canary” from its website.

The Block·2024/03/20 15:22

Is the Bitcoin halving priced in? Analysts compare BTC price targets vs previous halvings

The Bitcoin halving is less than 30 days away. Should investors expect a new all-time high or is the event already priced in?

Cointelegraph·2024/03/20 15:04

Greeks.live: All major term IVs have reached their highest levels in the past year, and the FOMO sentiment caused by the surge has disappeared

TechFlow·2024/03/20 14:53

TON Foundation launches Toncoin community rewards initiative worth over $100 million

Quick Take The TON Foundation has announced the launch of The Open League — a 30 million Toncoin community rewards initiative. Valued at over $115 million, the distribution will be allocated to competing projects and TON ecosystem users starting next month.

The Block·2024/03/20 14:52

In Defense of Meme Coins

Cointime·2024/03/20 14:37

Grayscale transferred a total of approximately 1,473 BTC to CEX

Bitget·2024/03/20 14:08

Bitcoin halving event now just a month away, expected to occur on 4/20

According to The Block’s halving countdown, Bitcoin’s next halving event, when miners’ block rewards are cut in half, is just a calendar month away. The estimated time remaining would see Bitcoin’s fourth halving arrive on April 20, with the block reward dropping from 6.25 BTC to 3.125 BTC.

The Block·2024/03/20 14:06

Bitcoin price retraces 30 days ahead of halving in historical pattern

Bitcoin price has historically retraced ahead of previous Bitcoin halvings, but when will it bounce back?

Cointelegraph·2024/03/20 13:31

STX Rallies Over 13% Amid Market Correction, Indicators Remain Bullish

Coinedition·2024/03/20 13:25

Bitcoin climbs back above $63,500 as market volatility causes spike in liquidations

The bitcoin price has climbed back above the $63,500 mark.Market volatility over the past day has resulted in the liquidation of over $150 million leveraged bitcoin positions.

The Block·2024/03/20 12:49

Flash

20:57

US Dollar Index Falls 0.09% on 16th

The US Dollar Index fell 0.09% on the 16th, closing at 99.540 in the foreign exchange market.

20:48

According to a document submitted to the U.S. Securities and Exchange Commission, an agreement between Arvinas Holding Company LLC and Pfizer indicates that both parties are eligible for milestone payments totaling up to 320 millions USD, along with a tiered royalty structure.

The document further clarifies the conditions and specific terms that trigger payment. Milestone payments will be distributed in phases based on the progress of R&D in the collaborative project, regulatory approvals, and commercialization outcomes at different stages. Tiered royalties mean that as product sales reach different thresholds, the rates will be adjusted accordingly, providing both parties with a more flexible revenue-sharing mechanism. This financial arrangement highlights both parties' confidence in the project's prospects and reflects the risk-sharing and profit-sharing models commonly seen in the biopharmaceutical industry. Although the details of the agreement have not been fully disclosed, the total potential revenue of up to $320 million undoubtedly injects strong financial momentum into the subsequent development of the project.

20:48

According to a filing submitted to the U.S. Securities and Exchange Commission, biotechnology company Arvinas Holding Company LLC, pharmaceutical giant Pfizer, and Rigel Pharmaceuticals obtained approval under the Hart–Scott–Rodino Antitrust Improvements Act on June 11, 2026.

This key development has removed regulatory obstacles for all parties to advance the previously announced licensing agreement. The conclusion of this agreement marks a new substantive phase in the related cooperation. Passing the HSR antitrust review is a crucial step in strategic collaborations involving intellectual property and market access. This usually means that regulatory authorities have determined the transaction will not materially harm competition in the relevant market. With this regulatory threshold crossed, all parties are expected to accelerate implementation of the detailed terms of the licensing agreement, boosting progress in related R&D or commercialization projects. This dynamic is being closely watched by industry observers.

Trending news

Tokenized asset market tops $43B as institutions accelerate blockchain adoption

Circle CEO Jeremy Allaire argues SEC is not suitable regulator for stablecoins

Bitget

News